3066 Pharmacokinetically (PK)-guided dosing of paclitaxel...

European Journal of Cancer 2015 / 09 Vol. 51

3066 Pharmacokinetically (PK)-guided dosing of paclitaxel in combination with carboplatin in advanced non-small cell lung cancer (NSCLC) is gender dependent: Updated results of the randomized CEPAC-TDM study

Joerger, M., Von Pawel, J., Kraff, S., Fischer, J.R., Gauler, T., Mueller, L., Reinmuth, N., Reck, M., Kimmich, M., Frank, M., Kopp, H.G., Behringer, D., Ko, Y.D., Ralf, H., Roessler, M., Kloft, C., H
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31708-7
Date:
September, 2015
File:
PDF, 63 KB
english, 2015
Conversion to is in progress
Conversion to is failed